Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronen Gabizon

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Nature Communications|May 18, 2026
α-Halothioamide warheads with enhanced cysteine reactivity and specificity for covalent protein labellingLászló Petri, Ronen Gabizon, Nikolett Péczka, et al.
Nature Communications|December 1, 2023
A simple method for developing lysine targeted covalent protein reagentsRonen Gabizon, Barr Tivon, Rambabu N Reddi, et al.
Elife|August 1, 2019
High-resolution and high-accuracy topographic and transcriptional maps of the nucleosome barrierZhijie Chen, Ronen Gabizon, Aidan I Brown, et al.
Frontiers in Oncology|May 31, 2021
Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL CellsYamit Shorer Arbel, Ben-Zion Katz, Ronen Gabizon, et al.
Journal of the American Chemical Society|March 25, 2021
Tunable Methacrylamides for Covalent Ligand Directed Release ChemistryRambabu N Reddi, Efrat Resnick, Adi Rogel, et al.
Nature Structural & Molecular Biology|July 20, 2010
The C terminus of p53 binds the N-terminal domain of MDM2Masha V Poyurovsky, Chen Katz, Oleg Laptenko, et al.
Journal of the American Chemical Society|June 11, 2020
Correction to Efficient Targeted Degradation via Reversible and Irreversible Covalent PROTACsRonen Gabizon, Amit Shraga, Paul Gehrtz, et al.
Journal of the American Chemical Society|May 6, 2020
Efficient Targeted Degradation via Reversible and Irreversible Covalent PROTACsRonen Gabizon, Amit Shraga, Paul Gehrtz, et al.
Cell Chemical Biology|June 26, 2021
An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitorDaniel Zaidman, Paul Gehrtz, Mihajlo Filep, et al.
Journal of Medicinal Chemistry|August 1, 2022
Optimization of Covalent MKK7 Inhibitors <i>via</i> Crude Nanomole-Scale LibrariesPaul Gehrtz, Shir Marom, Mike Bührmann, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Nature Communications|May 18, 2026
α-Halothioamide warheads with enhanced cysteine reactivity and specificity for covalent protein labellingLászló Petri, Ronen Gabizon, Nikolett Péczka, et al.
Nature Communications|December 1, 2023
A simple method for developing lysine targeted covalent protein reagentsRonen Gabizon, Barr Tivon, Rambabu N Reddi, et al.
Elife|August 1, 2019
High-resolution and high-accuracy topographic and transcriptional maps of the nucleosome barrierZhijie Chen, Ronen Gabizon, Aidan I Brown, et al.
Frontiers in Oncology|May 31, 2021
Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL CellsYamit Shorer Arbel, Ben-Zion Katz, Ronen Gabizon, et al.
Journal of the American Chemical Society|March 25, 2021
Tunable Methacrylamides for Covalent Ligand Directed Release ChemistryRambabu N Reddi, Efrat Resnick, Adi Rogel, et al.
Nature Structural & Molecular Biology|July 20, 2010
The C terminus of p53 binds the N-terminal domain of MDM2Masha V Poyurovsky, Chen Katz, Oleg Laptenko, et al.
Journal of the American Chemical Society|June 11, 2020
Correction to Efficient Targeted Degradation via Reversible and Irreversible Covalent PROTACsRonen Gabizon, Amit Shraga, Paul Gehrtz, et al.
Journal of the American Chemical Society|May 6, 2020
Efficient Targeted Degradation via Reversible and Irreversible Covalent PROTACsRonen Gabizon, Amit Shraga, Paul Gehrtz, et al.
Cell Chemical Biology|June 26, 2021
An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitorDaniel Zaidman, Paul Gehrtz, Mihajlo Filep, et al.
Journal of Medicinal Chemistry|August 1, 2022
Optimization of Covalent MKK7 Inhibitors <i>via</i> Crude Nanomole-Scale LibrariesPaul Gehrtz, Shir Marom, Mike Bührmann, et al.
Pageof 4